January 19, 2023
Via: Contract PharmaSun Pharmaceutical Industries and Concert Pharmaceuticals, Inc. entered a definitive agreement under which Sun Pharma will acquire Concert through an upfront payment of $576 million. Concert stockholders will also receive up to an additional $3.50 per share of common stock […]
March 30, 2023
March 28, 2023
March 23, 2023
March 16, 2023